Clinical trial • Phase I • Dermatology
Clinical trial in Atopic dermatitis
Phase I trial for Atopic dermatitis. 80 participants.
Overview
- Trial Therapeutic Area
- Dermatology
- Trial Disease
- Atopic dermatitis
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 13-03-2026
- First CTIS Authorization Date
- 30-04-2026
Trial design
Phase I trial across 1 site in Belgium.
- Target Sample Size
- 80
Recruitment
- Planned Sample Size
- 80
- Recruitment Window Months
- 25
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 80
Belgium
- Earliest CTIS Part Ii Submission Date
- 17-04-2026
- Latest Decision Or Authorization Date
- 30-04-2026
- Processing Time Days
- 13
- Number Of Sites
- 1
- Number Of Participants
- 64
Sites
- Site Name
- UZ Leuven
- Department Name
- Center for Clinical Pharmacology
- Principal Investigator Name
- Jan de Hoon
- Principal Investigator Email
- jan.dehoon@uzleuven.be
- Contact Person Name
- Jan de Hoon
- Contact Person Email
- jan.dehoon@uzleuven.be
Sponsor
Primary sponsor
- Full Name
- Regeneron Pharmaceuticals Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Related trials
Other published trials that may interest you.